Treatment of KPL-3M (TMB high) tumor-bearing mice with i.p. anti-PD-1 or IT CXCL9/10-DC monotherapy provided modest antitumor efficacy, with no observed tumor eradication. The gene discussed is CXCL9; the disease is neoplasm.